Rhythm Pharmaceuticals (RYTM) Depreciation & Amortization (CF) (2016 - 2021)
Rhythm Pharmaceuticals' (RYTM) quarterly Depreciation & Amortization (CF) came in at $315000.0 in Q3 2021, up 83.14% year-on-year from $172000.0 in Q3 2020, and down 0.63% on a QoQ basis from $317000.0 in Q2 2021.
Rhythm Pharmaceuticals (RYTM) Depreciation & Amortization (CF) (2016 - 2021) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $315000.0 in Q3 2021.
- On a quarterly basis, Depreciation & Amortization (CF) rose 83.14% year-over-year to $315000.0 in Q3 2021; TTM through Jun 2022 was $315000.0, a 63.71% decrease from a year earlier, with the FY2020 full-year figure at $690000.0, down 17.27% from the prior year.
- Depreciation & Amortization (CF) for Q3 2021 stood at $315000.0, down from $317000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for RYTM reached as high as $317000.0 in Q2 2021 and fell as low as $54000.0 in Q1 2017.
- Historically, Depreciation & Amortization (CF) has averaged $159052.6 across 5 years, with a median of $173000.0 in 2020.
- Across the five-year window, Depreciation & Amortization (CF) jumped 301.64% in 2019 and slumped 31.84% in 2020, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $60000.0 in 2017, then surged by 256.67% to $214000.0 in 2018, then fell by 10.75% to $191000.0 in 2019, then slipped by 6.81% to $178000.0 in 2020, then surged by 76.97% to $315000.0 in 2021.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $315000.0 in Q3 2021, $317000.0 in Q2 2021, and $201000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Rhythm Pharmaceuticals | 6.98 Bn | 6.64 Bn | 52.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 315,000.00 |
| Sep 30, 2021 | 315,000.00 |
| Jun 30, 2021 | 317,000.00 |
| Jun 30, 2021 | 317,000.00 |
| Mar 31, 2021 | 201,000.00 |
| Mar 31, 2021 | 201,000.00 |
| Dec 31, 2020 | 178,000.00 |
| Dec 31, 2020 | 178,000.00 |
| Sep 30, 2020 | 172,000.00 |
| Sep 30, 2020 | 172,000.00 |
| Jun 30, 2020 | 173,000.00 |
| Jun 30, 2020 | 173,000.00 |
| Mar 31, 2020 | 167,000.00 |
| Mar 31, 2020 | 167,000.00 |
| Dec 31, 2019 | 191,000.00 |
| Dec 31, 2019 | 191,000.00 |
| Sep 30, 2019 | 191,000.00 |
| Sep 30, 2019 | 191,000.00 |
| Jun 30, 2019 | 207,000.00 |
| Jun 30, 2019 | 207,000.00 |